A commentary by a CITF-funded researcher, published by the C.D. Howe Institute, discusses the differences in implementing vaccination mandates in businesses vs. in government sectors.
A CITF-funded study, published in Science of the Total Environment, demonstrated that the ratio of SARS-CoV-2 wastewater signals to clinical cases (WC ratio) would add more value to wastewater-based surveillance (WBS).
A commentary by a CITF-funded researcher, published in Intelligence Memos, explores the extent to which privacy laws restrict businesses’ ability to verify an individual’s vaccination status.
A CITF-funded study, published in Science of the Total Environment, demonstrated that wastewater-based surveillance (WBS) for SARS-CoV-2 could indicate disease incidence and predict disease burden at various stages of the pandemic.
A commentary by a CITF-funded researcher, published by C.D. Howe Institute, highlights four fundamental choices for the design of vaccine passport systems that bear upon potential privacy considerations for Canadians.
A CITF-funded study, published in Clinical Microbiology Reviews, provides a thorough overview of the usefulness of wastewater-based surveillance (WBS), during and after the COVID-19 pandemic.
A CITF-funded study, published in Science of the Total Environment, aimed to address the knowledge gap on the implementation of reliable wastewater-based surveillance (WBS) in small or rural communities to track the incidence of SARS-CoV-2 and other pathogens or biomarkers.
A CITF-funded study, published in Pathogens, found that overall, the passive sampler is a rapid, reliable, and cost-effective device for use in wastewater surveillance. The passive sampler containing absorbent materials or membranes is placed in a targeted sewage catchment to capture viruses for a defined period of time.
A CITF-funded study, published by the C.D. Howe Institute, underscored that vaccine passports are aimed at protecting unvaccinated people or people who cannot be vaccinated from the risk of serious illness from COVID-19.
A study carried out by SeroTracker (a CITF-funded project), in partnership with the World Health Organization, found global SARS-CoV-2 seroprevalence (due to infection or vaccination or both) was 45.2% by end of June 2021.